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For radiofrequency (RF) ablation in thicker regions of the left atrium (LA) may require 26 
increased ablation energy in order to achieve effective transmural lesions. 27 
Consequently, many cases of recurrent atrial fibrillation (AF) post ablation may be due 28 
to thicker-than-normal atrial tissue. The aim of this study was to test the hypotheses that 29 
patients with recurrent AF have thicker tissue overall and that electrical reconnection is 30 
more likely in regions of thicker tissue. 31 
 32 
Methods and Results 33 
Retrospective analysis was performed on 86 CT images acquired preoperatively from a 34 
cohort of 119 patients who had undergone RF ablation for AF. Of these, 33 patients 35 
experienced recurrence of AF within one year of initial treatment and 29 returned for a 36 
repeat ablation. For each patient, LA wall thickness (LAWT) was measured from the 37 
images in 12 anatomical regions using custom software. Patients with recurrent AF had 38 
larger LAWT compared to successfully treated patients (1.6 ± 0.6 mm vs. 1.5 ± 0.5 mm, 39 
p < 0.001) and reconnection was found to be at regions of thicker tissue (1.6 ± 0.6 mm, 40 
p = 0.038) compared to non-reconnected regions (1.5 ± 0.5 mm). The superior right 41 
posterior wall of the LA was significantly related to both recurrence (p = 0.048) and 42 
reconnection (p = 0.014). 43 
 44 
Conclusion 45 
Increased LAWT has a small, but significant effect on post-ablation recurrence and 46 
reconnection. Measures of LAWT may facilitate appropriate dosing of RF energy, but 47 
other factors will be critical in transmural lesion formation and ablation success. 48 
 49 
KEYWORDS: 50 
left atrium, wall thickness, CT, atrial fibrillation, radiofrequency catheter ablation, 51 
electrical reconnection 52 
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INTRODUCTION 54 
Radiofrequency (RF) catheter ablation has emerged as a front-line intervention for atrial 55 
fibrillation (AF),1 but requires long, circular lesions that are both continuous and 56 
transmural along the entire length. This challenge has been recently tackled using 57 
measures of contact force incorporated into indices of ablation lesion production. 58 
Correctly dosing RF energy has obvious limitations without knowing the thickness of 59 
underlying tissue. Overdosing may contribute to collateral damage and complications 60 
such as the rare, but frequently fatal, atrioesophageal fistula.2-4 Underdosing may limit 61 
transmurality and contribute to electrical reconnection and thus to a large number of 62 
repeat procedures.1, 5 Furthermore, developing transmural lesions in thicker regions 63 
may be more sensitive to catheter instability. Knowledge of left atrial wall thickness 64 
(LAWT) is not currently incorporated into ablation delivery, despite previous research 65 
that shows clear inter- and intra-patient variability in LAWT.6-9 At present, clinical 66 
judgment is the major determinant of RF dosing, where clinicians may err on the side of 67 
underdosing energy rather than risk the fatal complications of overdosing RF. Dosing 68 
RF energy based on direct LAWT measurements may be an effective way to safely 69 
create continuous, transmural lesions. 70 
 71 
The hypothesis that greater LAWT correlates with ablation failure has been scantly 72 
tested, and with limited results. One study examined the LAWT of patients undergoing 73 
RF ablation for paroxysmal AF and found that increased thickness seemed to correlate 74 
with ablation failure, but the difference was statistically significant at only 1 of 9 locations 75 
measured.10 Another study investigated the LAWT of RF ablation patients with 76 
hypertrophic cardiomyopathy and found significant, but small thickness differences in 2 77 
of 11 locations and a statistically significant effect on ablation success could not be 78 
established.11 79 
 80 
These previous studies examined overall success/failure of RF ablation in relation to 81 
LAWT at specific locations, but due to the number of individual ablation lesions created 82 
per intervention, a more localized analysis may be appropriate. By considering electrical 83 
reconnection at specific locations in relation to LAWT, the relationship between LAWT 84 
and ablation success can be examined with finer granularity. 85 
 86 
Using a custom, semi-automated method of LAWT, we investigated two hypotheses on 87 
the relationship between greater LAWT and ablation success. First, that patients with 88 
recurrent AF have thicker tissue compared to who were successfully treated by first-89 
time ablation, and second, that electrical reconnection was more likely at regions of 90 
thicker tissue. 91 
 92 
METHODS 93 
Study Population 94 
The patient data for this study were drawn from a previous study.12 To summarize, 119 95 
patients from a single site, diagnosed with paroxysmal AF, were originally enrolled for a 96 
study on the efficacy of pulmonary vein isolation (PVI) with incomplete antral ablation 97 
lines. Patients were preoperatively imaged with contrast-enhanced cardiac CT to assist 98 
with intraoperative guidance. Patients were approved for, and treated by, first-time RF 99 
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ablation under CARTO (Biosense Webster Inc., USA) guidance using non-contact force 100 
catheters and randomized for either incomplete ablation lines – stopping when electrical 101 
isolation was achieved (n = 60), or complete ablation lines – continuing ablation until a 102 
complete loop was formed (n = 59). The study was performed before the availability of 103 
force-contact catheters at our center. In both groups, pulmonary veins (PV) were 104 
isolated as pairs (superior and inferior together in a single loop). Patients were followed 105 
for twelve months, and in recurrent cases, repeat ablations were performed under 106 
CARTO guidance with non-contact force catheters, but imaging was not repeated. 107 
Recurrence was defined as symptomatic or asymptomatic AF of at least 30 seconds. 108 
Not all patients experiencing recurrence were treated a second time, but in those that 109 
were, ablation locations for repeat ablations were selected to achieve electrical isolation 110 
only and did not duplicate the original ablation pattern. 111 
 112 
For the current study, 33 patients from the original study were excluded due to lack of 113 
CT images (n = 30), outcome data (n = 2), or abandonment of the procedure (n = 1). All 114 
treatments were completed before the inception of this study. The current study was 115 
approved by the Research Ethics Board of Western University. 116 
 117 
CT Imaging and 3D Image Processing 118 
CT images were acquired using a GE Discovery CT750 HD or GE LightSpeed VCT (GE 119 
Healthcare, UK) using a clinical protocol for contrast-enhanced cardiac CT imaging for 120 
RF ablation. Scans were gated to generate images at 70% of the R-R interval; 100 mg 121 
of Isovue 370 or Visipaque 270 was injected intravenously to enhance the blood pool. 122 
Pixel spacing varied from 0.39 to 0.88 mm and slice thickness was 0.625 or 1.25 mm. 123 
Prior to the ablation procedures, 3D models were constructed from the CT images by an 124 
expert electrophysiology technician for integration with the CARTO system. 125 
 126 
Computer-Assisted LAWT Measurement 127 
A computer-assisted LAWT measurement method was developed using the MeVisLab 128 
(MeVis Medical Solutions AG, Germany) medical imaging software development 129 
framework. This software is capable of calculating a LAWT value for any point on the 130 
endocardium of the left atrial wall based on the Hounsfield unit (HU) intensities of the 131 
CT image near that point. This method combines the thresholding approach of 132 
classifying left atrial anatomy,11, 13-16 patient-specific modeling of image intensity in CT, 133 
the ability to measure in any 3D direction, and the precision and repeatability of 134 
automated measurement. 135 
 136 
For each CT image, patient-specific HU thresholds were determined for the endocardial 137 
boundary separating the blood pool from myocardium, and the epicardial boundary 138 
separating the myocardium from fat or other surrounding tissues. The expected 139 
intensities for blood and myocardium were first determined by sampling large, 140 
contiguous regions on single axial image slices and calculating the mean and standard 141 
deviation intensities of the samples. The blood pool was sampled inside the left atrium 142 
and the myocardium was sampled at either the apex or the superior aspect of the left 143 
ventricle. The endocardial threshold was chosen to be the mean of the blood pool and 144 
myocardium samples, and the epicardial threshold was chosen to be two standard 145 
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deviations below the mean myocardial intensity. This was necessary due to the 146 
possibility of multiple types of tissues being adjacent to the epicardial side of the atrial 147 
wall and the resulting variation in the ideal threshold value. 148 
 149 
Measurement locations were selected using an interactive graphical user interface. 150 
Elements of this interface are shown in Figure 1a-b. A mouse was used to manually 151 
select individual measurement locations on the 3D model of the left atrium either by 152 
directly choosing a location on the model, or by selecting a nearby location on a 2D CT 153 
slice. The 3D model was smoothed using Laplacian mesh smoothing (5 passes, 154 
smoothing factor of 0.9) to reduce angulation errors in the direction of the ray 155 
perpendicular to the model surface. A line segment was then defined at the 156 
measurement location, perpendicular to the surface, extending from 5 mm inside to 10 157 
mm outside the atrium. 158 
 159 
The CT image was resampled using trilinear interpolation at 0.1 mm intervals along this 160 
line to obtain a HU intensity profile, and the intensity profile was then classified into 161 
sections of blood pool, myocardium, or fat/external tissue based on the patient-specific 162 
thresholds. The section of the intensity profile corresponding to the atrial wall was then 163 
selected, and the length of myocardial tissue in this section was recorded as the 164 
thickness measurement. An example profile and measurement is shown in Figure 1c. 165 
Each profile was manually checked for indeterminate cases or obvious misclassification. 166 
In these cases, the measurement was not used, and the point selection was repeated. 167 
 168 
Experimental Data Collection 169 
The regions of the left atrium targeted for ablation were subdivided into 12 regions as 170 
shown in Figure 2. Due to difficulties in measuring and ablating directly on the left lateral 171 
ridge, the left anterior locations (superior and inferior) were defined inside the PV, within 172 
~10 mm of the ostia. The LAWT for each region was measured using the previously 173 
described method five times, the high and low values were discarded, and the mean of 174 
the three middle values was considered to be the thickness for the region. Two regions 175 
where reasonable measurements could not be determined after many attempts, and 13 176 
regions where the measurement range (the difference between the largest and smallest 177 
of the three middle measurements) was large (more than three standard deviations over 178 
the mean measurement range for all regions) were also excluded. The remaining 1017 179 
measurements (99%) were used for the analysis of recurrence. 180 
 181 
For the analysis of reconnection, it was necessary to classify each region as 182 
reconnected or not reconnected. In the original study,12 patients were randomized to 183 
initial PVI by either complete ablation lines or incomplete ablation lines, where ablation 184 
was concluded when the PV demonstrated entry and exit block. If a second intervention 185 
was performed, sites of previous ablation were assessed for conduction recovery and if 186 
recovery was found, ablated again. Reconnected regions are those that were ablated in 187 
both the initial treatment and the second treatment. Non-reconnected regions are those 188 
that were ablated once only, on the first treatment. All ablated regions in patients that 189 
did not experience recurrence were considered to be non-reconnected.  Regions that 190 
were never ablated in the initial treatment due to the use of incomplete ablation lines (n 191 
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= 57 regions) were excluded and patients that experienced recurrence but did not 192 
undergo a second treatment (4 patients, n = 44 regions) were excluded from this 193 
analysis. In total, 70 regions reconnected and 846 regions were not reconnected. 194 
 195 
Statistical Analysis 196 
Descriptive statistics for CT images and LAWT measurements were collected. All 197 
continuous data are expressed as mean ± standard deviation. Statistical analysis was 198 
performed using Prism 6 (Graphpad Software Inc., USA) with a p < 0.05 considered to 199 
be statistically significant. 200 
Before testing for statistical significance, normality of all measurements was tested 201 
using the D’Agostino-Pearson normality test. The relationship between LAWT and 202 
recurrence was tested by comparing the regional LAWTs of repeated vs. non-repeated 203 
cases using 2-way ANOVA. Post hoc analysis using Fisher’s LSD (unprotected, two-204 
tailed) on subgroups was performed to find specific regions where the effect of 205 
thickness was most significant. 206 
 207 
The relationship between the LAWT and local reconnection was tested by comparing 208 
the wall thicknesses of reconnected vs. non-reconnected regions.  Due to the small 209 
numbers of repeated ablation points, all measurements were pooled and tested using 210 
the two-tailed Mann-Whitney U test. Post hoc analysis using Fisher’s LSD (unprotected, 211 
two-tailed) on subgroups was performed to find specific regions of thickness difference. 212 
 213 
RESULTS 214 
Patient Characteristics 215 
Baseline and imaging characteristics of the patients are summarized in Table 1. In 216 
general, the mean intensities of myocardium were fairly consistent, but there was 217 
considerable variability (noise) within each image. There was much higher variability in 218 
the mean intensity of the blood pool due to the effect of variable mixing of contrast 219 
agent and blood. Thus the endocardial threshold (250 ± 55 HU) was much more 220 
variable compared to the epicardial threshold (32 ± 30 HU). The distributions of 221 
calculated threshold values are shown in Figure 3.  222 
 223 
Overall measurements and Descriptive statistics 224 
Across all patients, LAWT was found to be 1.5 ± 0.5 mm but with significant variation 225 
between regions (p < 0.001 by 1-way ANOVA). The distribution of measurements by the 226 
D’Agostino-Pearson normality test was found to be non-normal overall, but with some 227 
subsets of the data passing as significantly close to normal. Thus, non-parametric 228 
statistics were used for the reconnection analysis due to the small number of individual 229 
reconnection locations. A summary of mean measurements by region is given in the 230 
second column of Table 2. Interestingly, the right side of the left atrium was found to be 231 
significantly thicker than the left side in all six relative locations (e.g. right roof vs. left 232 
roof; p < 0.001 overall by 2-way ANOVA, p < 0.01 for each of the six pairs by Fisher’s 233 
uncorrected LSD post-test.) 234 
 235 
Effect of LAWT on Recurrence 236 
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ANOVA showed that increased LAWT was found to significantly correlate with 237 
increased recurrence (p = 0.001). Post hoc analysis showed significant effects at three 238 
locations: the right high posterior (p = 0.048), right low anterior (p = 0.024), and left high 239 
anterior (p = 0.023). While the effect was not statistically significant in other locations, 240 
the general trend was in the same direction. These regional effects on overall 241 
recurrence are summarized in Table 2. Although ANOVA showed an independent 242 
correlation of greater LAWT with increased chance of recurrence, the effect size was 243 
small – on the order of 0.1 or 0.2 mm. 244 
 245 
Effect of LAWT on Regional Reconnection 246 
After pooling all measurements, thicker LAWT was found to correlate with reconnection 247 
(p = 0.038). Post hoc analysis showed a significant effect at the right high posterior 248 
region  (p = 0.014) and no significant effect at other regions. The general trend for non-249 
statistically significant regions was also in the same direction, but the effect was weaker 250 




LAWT Correlates with Recurrence and Reconnection 255 
We have described a semi-automated method of regional CT-derived measurement of 256 
LAWT and tested whether these measures are associated with clinically important 257 
outcomes.  The results of this analysis show that in RF ablation of the left atrium in 258 
paroxysmal AF patients, increased LAWT correlates with poorer ablation outcomes. 259 
Regions of thicker tissue are associated with sites of electrical reconnection and 260 
increased chance of recurrence. These results augment and clarify results by Suenari et 261 
al.,10 which showed that measurements at the left lateral ridge correlated significantly 262 
with recurrence, and by Takahashi et al.,13 which showed ATP-provoked dormant 263 
conduction in areas of thicker tissue. These related studies used slightly different 264 
measurement and analysis methods, but support the overall hypothesis that thicker 265 
tissue is more difficult to ablate successfully. 266 
 267 
Importance of LAWT: 268 
Despite the statistical significance of the main results, the clinical significance of LAWT 269 
is uncertain. The statistical results show a link between LAWT and ablation failure but 270 
the magnitudes of the mean detected differences are small, both in absolute terms and 271 
relative to the overall variation in LAWT. Takahashi et al.13 similarly showed significant 272 
but small differences, as did Suenari et al.10 273 
 274 
Can such small differences in LAWT be a real contributor to ablation outcomes? 275 
Clearly, LAWT is but one important parameter impacting outcomes. Permanent antral 276 
PVI requires a continuous transmural linear lesion encircling the PV. It is likely that 277 
catheter stability, power, force contact (unavailable for this study) and thickness all 278 
interact to determine both contiguity and transmurality at any site(s). As force contact 279 
and catheter stability were not evaluated in this study, their contribution to lesion failure 280 
cannot be evaluated. However, given an overall variability in both contact force and 281 
catheter stability during ablation, it is not surprising that thicker tissue is more resistant 282 
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to ablation, implying that there may be a higher threshold for successful ablation at 283 
these sites. Thicker regions may also require better contact during ablation due to the 284 
need to create a deeper lesion to achieve transmurality. 285 
 286 
It is striking that force contact and catheter stability have received more attention than 287 
LAWT in determining ablation outcomes, likely because of the difficulty in accurately 288 
measuring LAWT. As ablation algorithms incorporate force-time integrals and power to 289 
measure RF dose and predict lesion depth, LAWT will likely become investigated more 290 
extensively and evaluated as the ablation target. Recent advances in controlling 291 
catheter contact force,17 rather than simply measuring it, will likely allow more precise 292 
delivery of a prescribed RF dose in the future. Effective use of this technology will 293 
require equally precise targets. With further validation, automated measurements with 294 
graphical visualizations such as shown in Figure 4, may be used to assist in determining 295 
these targets.  296 
 297 
Limitations 298 
Small sample sizes, especially in the number of reconnection locations, limited the 299 
statistical power of some of our subgroup analyses. However, the combined data 300 
confirmed our hypothesis that, in general, thicker tissues are more resistant to 301 
transmural ablation, resulting in greater recurrence and reconnection. 302 
All patients were assumed to have arrhythmias originating in the PV but it is possible 303 
that some non-PV triggers contributed to AF recurrence. Although we could not identify 304 
these cases directly, PV ablation gap production appeared to be related to LAWT.  We 305 
are aware of no relationship to non-PV triggers that would systematically bias the 306 
observation related to LAWT.  307 
The measurement method developed for this study is based on a patient-specific, 308 
mathematical model of CT images and has not been rigorously validated for accuracy. 309 
Validating the accuracy of LAWT measurement is difficult because of a lack of a gold 310 
standard for LAWT measurements – image-based methods are not an independent 311 
standard to measure against, and pathology specimens are known to shrink. To the 312 
best of our knowledge, there is no validated method of LAWT measurement. Validation 313 
of repeatability has not been tested with multiple observers. Due to the use of 314 
automation however, this method allows objective, repeatable measurements that are 315 
suitable as a relative measure of LAWT. Low image quality and challenging anatomy 316 
also create difficulties in measuring LAWT, decreasing the statistical power of this. 317 
Future use of LAWT for ablation planning may require optimized CT protocols to better 318 
isolate the atrial wall and derive accurate thickness measurements. 319 
 320 
CONCLUSION 321 
A semi-automated, CT-based LAWT measure has been developed and has been 322 
shown to correlate to clinically relevant outcomes: post-operative recurrence of AF, and 323 
specifically with local electrical reconnection. This measure may be used to assist in 324 
dosing RF energy, but given the small magnitudes of the detected differences, other 325 
factors (such as contract force or catheter stability) will be critical in transmural lesion 326 
formation and ablation success. Increasing RF ablation success rates will require an 327 
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improved understanding of dose target parameters such as LAWT in combination with 328 
the development of methods of improving the accuracy of RF dosing. 329 
 330 
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 401 
Figure 1 Measurement of LAWT. A: A patient-specific model of the left atrial blood 402 
pool is illustrated along with a line perpendicular to the LA surface (cyan); a 2D CT 403 
image re-sliced in the direction of the selected line is also shown. B: The CT image was 404 
resampled along the selected ray from inside the atrium toward the epicardium. Actual 405 
calculations were made in 3D. C: The atrial wall was identified from the CT image 406 
intensity of the resampled line using the defined endo- and epicardial thresholds.   407 
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 408 
Figure 2 Schematic of LAWT measurement locations. 12 locations (6 per side) 409 
were selected around the pulmonary-vein antra where circumferential pulmonary vein 410 
ablation would be performed. Left lateral ridge locations were taken inside the 411 
pulmonary vein within ~10 mm of the antrum. Ant = anterior; Post = posterior; LLR = left 412 
lateral ridge; RSPV = right superior pulmonary vein; RIPV = right inferior pulmonary 413 
vein; LSPV = left superior pulmonary vein; LIPV = left inferior pulmonary vein. 414 
  415 
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 416 
Figure 3 Graph of calculated endocardial and epicardial thresholds used to 417 
determine boundaries of the atrial wall. Mean and standard deviation of the 418 
measurements are also plotted.  419 
  420 
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 421 
Figure 4 Posterior view of 3D rendering of example left atrium with color-coded 422 
thickness map. Measurements were generated automatically and applied without 423 
manual vetting. Slow variation in thickness from region-to-region can be seen by shifts 424 
in average color. Rapid color variation is due to noise in the CT data and very thick 425 
measurements between the inferior pulmonary veins are caused by misclassification of 426 
the esophagus rather than exceptionally thick atrial wall. 427 
  428 
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Table 1 Baseline characteristics of patients. 429 
Characteristic  
Clinical  
Total number of patients 86 
Age (years) 59.7 ± 8.8 
Male Sex 65 (75.6 %) 
Hypertension 34 (39.5 %) 
Diabetes Mellitus 3 (3.5 %) 
Stroke/TIA/PAE 1 (1.2 %) 
Congestive Heart Failure 1 (1.2 %) 
Amiodarone 18 (20.9 %) 
Sotalol 19 (22.1%) 
Beta Blocker 17 (19.8 %) 
Calcium Channel Blocker 11 (12.8 %) 
Digoxin 1 (1.2 %) 
Left Atrial Size (mm)* 40.8 ± 6.0 (n=70) 
CT-image derived  
Blood Pool Intensity Mean (HU) 388 ± 96 
Blood Pool Intensity SD (HU) 50 ± 15 
Muscle Intensity Mean (HU) 111 ± 22 
Muscle Intensity SD (HU) 40 ± 11 
Endocardial Boundary Threshold (HU) 250 ± 55 
Epicardial Boundary Threshold (HU) 32 ± 30 
 430 
Values shown are number (%) or mean ± SD between subjects. *Clinically derived from 431 
echocardiograms. HU = Hounsfield unit. 432 
  433 
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(n = 86) 
No recurrence 
(n = 53) 
Recurrenc
e 
(n = 33) 
P-
value 
     
All regions 1.5 ± 0.5 1.5 ± 0.5 1.6 ± 0.6 0.001 
Right roof 1.7 ± 0.7 1.7 ± 0.6 1.8 ± 0.8 0.404 
Right high 
anterior 
1.7 ± 0.5 1.7 ± 0.6 1.7 ± 0.5 0.838 
Right low anterior 1.6 ± 0.5 1.5 ± 0.4 1.8 ± 0.7 0.024 
Right high 
posterior 
1.7 ± 0.5 1.6 ± 0.4 1.8 ± 0.6 0.048 
Right low 
posterior 
1.5 ± 0.5 1.5 ± 0.5 1.5 ± 0.4 -0.945 
Right floor 1.6 ± 0.5 1.5 ± 0.5 1.6 ± 0.6 0.281 
Left roof 1.5 ± 0.6 1.4 ± 0.5 1.5 ± 0.7 0.239 
Left high anterior 1.4 ± 0.5 1.3 ± 0.4 1.5 ± 0.6 0.023 
Left low anterior 1.4 ± 0.5 1.4 ± 0.5 1.4 ± 0.4 0.890 
Left high posterior 1.4 ± 0.5 1.3 ± 0.4 1.4 ± 0.6 0.176 
Left low posterior 1.3 ± 0.4 1.3 ± 0.4 1.3 ± 0.3 -0.590 
Left floor 1.4 ± 0.4 1.3 ± 0.5 1.4 ± 0.4 0.434 
     
Measurements shown as mean ± SD in mm. 437 
P-values per 2-way (region, recurrence) ANOVA for all regions. Fisher’s LSD for 438 
individual regions. 439 
 440 
  441 
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Table 3 Left atrial wall thickness by region. Reconnection vs. no reconnection. 442 
 443 





     
All regions 1.5 ± 0.5 1.5 ± 0.5 (846) 1.6 ± 0.6 
(70) 
0.038 
Right roof 1.8 ± 0.7 1.7 ± 0.6 (65) 2.0 ± 0.8 (9) 0.092 
Right high anterior 1.7 ± 0.6 1.7 ± 0.6 (71) 1.5 ± 0.4 (4) -0.475 
Right low anterior 1.6 ± 0.6 1.6 ± 0.6 (76) 1.7 ± 0.6 (5) 0.555 
Right high 
posterior 
1.7 ± 0.5 1.6 ± 0.5 (72) 2.1 ± 0.6 (7) 0.014 
Right low posterior 1.5 ± 0.5 1.5 ± 0.5 (67) 1.6 ± 0.5 
(10) 
0.524 
Right floor 1.6 ± 0.5 1.6 ± 0.5 (73) 1.8 ± 0.6 (6) 0.363 
Left roof 1.5 ± 0.6 1.5 ± 0.6 (70) 1.3 ± 0.3 (7) -0.352 
Left high anterior 1.3 ± 0.4 1.3 ± 0.4 (71) 1.5 ± 0.5 (4) 0.608 
Left low anterior 1.4 ± 0.5 1.4 ± 0.5 (74) 1.5 ± 0.4 (5) 0.647 
Left high posterior 1.3 ± 0.5 1.3 ± 0.5 (69) 1.3 ± 0.3 (5) 0.999 
Left low posterior 1.3 ± 0.4 1.3 ± 0.4 (70) 1.2 ± 0.3 (5) -0.833 
Left floor 1.4 ± 0.5 1.4 ± 0.5 (68) 1.3 ± 0.2 (3) -0.953 
     
 444 
Measurements shown as mean ± SD in mm. 445 
P-values per Mann-Whitney U on pooled measurements. Fisher’s LSD for individual 446 
regions. 447 
 448 
